Thomas Hackenbeck

Statistics

Publications

Citations

729

H-Index

Active since

2003

Affiliations

Friedrich-Alexander-Universität Erlangen-Nürnberg(Current)

University of Cologne

Inserm

University of Freiburg

Charité - Universitätsmedizin Berlin

Thomas Hackenbeck is an author at Friedrich-Alexander-Universität Erlangen-Nürnberg specializing in life sciences, cellular responses to hypoxia, and hypoxia adaptation.

Publications per year

2003–2024

Publications

Hypoxia‐inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia‐inducible factor‐1

Tina Gimm, Melanie Wiese, Barbara Teschemacher et al. · The FASEB Journal · 2010 · 153 citations

Veterinary Medicine, Cell Biology, Oncology +17

Renal fibrosis is the common feature of autosomal dominant tubulointerstitial kidney diseases caused by mutations in mucin 1 or uromodulin

Arif B. Ekici, Thomas Hackenbeck, Vincent Morinière et al. · Kidney International · 2014 · 106 citations

Medicine, Genetics, Nephrology +16

Renal Tubular HIF-2α Expression Requires VHL Inactivation and Causes Fibrosis and Cysts

Ruth Schietke, Thomas Hackenbeck, Maxine Tran et al. · PLoS ONE · 2012 · 87 citations · Full text

Medicine, Pathobiology, Pathology +17

HIF-1 or HIF-2 induction is sufficient to achieve cell cycle arrest in NIH3T3 mouse fibroblasts independent from hypoxia

Thomas Hackenbeck, Karl X. Knaup, Ruth Schietke et al. · Cell Cycle · 2009 · 61 citations · Full text

Life Sciences, Cell Biology, Physiology +17

The Tumor Gene Survivin Is Highly Expressed in Adult Renal Tubular Cells

Philipp Lechler, Xiaoqing Wu, Wanja M. Bernhardt et al. · American Journal Of Pathology · 2007 · 56 citations · Full text

Medicine, Molecular Biology, Oncology +12

1–5 of 14